The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PRIME-ROSE: A blueprint for implementing precision cancer medicine in Europe.
 
Gro Live Fagereng
Research Funding - AstraZeneca (Inst); Illumina (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Henk van der Pol
No Relationships to Disclose
 
Tina Kringelbach
No Relationships to Disclose
 
Ulrik Lassen
Honoraria - AstraZeneca
Research Funding - Roche, BMS, Genmab, Lilly, Pfizer, GSK, Incyte, Novartis, JohnsonJohnson
 
Beatrice Mainoli
No Relationships to Disclose
 
Kristoffer Rohrberg
Honoraria - Amgen; Amgen; AstraZeneca; Bayer
Consulting or Advisory Role - Abbvie; Genmab; MSD Oncology
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bioinvent (Inst); BioNTech SE (Inst); Bristol-Myers Squibb (Inst); CDR-Life (Inst); Daiichi Sankyo Europe GmbH (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Loxo (Inst); Merus (Inst); MonTa Biosciences (Inst); MSD (Inst); Navire (Inst); Novartis (Inst); Orion Clinical (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Repare Therapeutics (Inst); Roche/Genentech (Inst); Turning Point Therapeutics (Inst)
 
Edita Baltruskeviciene
Honoraria - Amgen; AstraZeneca; SERVIER
Consulting or Advisory Role - Takeda
Research Funding - SERVIER (Inst)
Travel, Accommodations, Expenses - MSD
 
Jean-Yves Blay
Leadership - Transgene
Honoraria - AstraZeneca; Bayer; BMS; Deciphera; Ignyta; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Deciphera; Deciphera; Deciphera; GlaxoSmithKline; Karyopharm Therapeutics; Pharmamar; Roche
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); DEciphera (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); OSE Pharma (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Katriina Jalkanen
Employment - Faron Pharmaceuticals (I)
Stock and Other Ownership Interests - Curify Labs; Faron Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - Bayer (Inst); Lilly (Inst); Novartis (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Elisa Bjørgo
No Relationships to Disclose
 
Sahar van Waalwijk van Doorn-Khosrovani
No Relationships to Disclose
 
Julio Oliveira
Leadership - Portuguese Oncology Institute of Porto
 
Sarah Halford
Consulting or Advisory Role - ISPEP; Medscape; Roche
 
Matthew Krebs
Honoraria - Roche
Consulting or Advisory Role - Achilles Therapeutics; Bayer; Guardant Health; Janssen; OM Pharma; Roche; Seagen; Zai lab
Speakers' Bureau - BMS; Eisai; Guardant Health; Janssen; Roche
Research Funding - Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BerGenBio; BerGenBio; BMS; Immutep; Janssen; Roche; Roche; Zai Lab
 
Åslaug Helland
No Relationships to Disclose
 
Loic Verlingue
Leadership - Resolved
Consulting or Advisory Role - Adaptherapy
Research Funding - Bristol-Myers Squibb
 
Hans Gelderblom
Research Funding - Abbisko Therapeutics (Inst); AmmaxBio (Inst); Blueprint Medicines (Inst); Deciphera (Inst); InhibRx (Inst); Ipsen (Inst); SynOX (Inst)
Travel, Accommodations, Expenses - Merck (Inst)
 
Kjetil Tasken
Employment - Vidd Health AS (I)
Stock and Other Ownership Interests - Ledidi; Serca Pharmaceuticals
Consulting or Advisory Role - Serca Pharmaceuticals
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Illumina (Inst); Incyte (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Stock and Stock options, and royalty agreement through Oslo University Hospital / University of Oslo Tech Transfer Office Inven2 AS.
(OPTIONAL) Uncompensated Relationships - Vidd Health AS